Skip to main content
Home Beijing 2022 Winter Games
  • News
  • Galleries
  • Medals
  • Schedule
  • Home
  • News
  • Sports
  • Obituaries
  • Opinion
  • Calendar
  • Features
  • Entertainment
Arthritis
FILE - In this Jan. 7, 2021 file photo, an Israeli military paramedic prepares a Pfizer COVID-19 vaccine, to be administered to elderly people at a medical center in Ashdod, southern Israel. On Friday, April 23 The Associated Press reported on social media posts that misrepresented a report from doctors in Israel claiming shingles may be a side effect of the vaccine. (AP Photo/Tsafrir Abayov, File)
NOT REAL NEWS: A look at what didn't happen this week

By The Associated Press Apr. 23, 2021 12:23 PM EDT

FILE - The Eli Lilly corporate headquarters is pictured April 26, 2017, in Indianapolis. A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday, Sept. 14, 2020, from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases. (AP Photo/Darron Cummings, File)
Anti-inflammatory drug may shorten COVID-19 recovery time

By Marilynn Marchione Sep. 14, 2020 10:31 AM EDT

AP Sports | © 2022 Associated Press
  • Privacy Policy
  • Terms of Use
  • AP News
  • AP Images
  • ap.org